In a statement, Northwell Health announced that Ethan Ertel, an M.D./Ph.D. student from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, will join 黑料吃瓜资源 (CSHL) and Northwell teams researching glioblastoma. Ertel will contribute to collaborative laboratory research overseen by CSHL Professor Alea Mills and Northwell鈥檚 John Boockvar. The graduate student will investigate novel therapeutic strategies for glioblastoma, one of the most aggressive forms of brain cancer. This opportunity is made possible through annual funding from the .
鈥淲e are excited to welcome Ethan Ertel, an aspiring physician-scientist, to our lab, knowing his unique M.D./Ph.D. perspective will be invaluable in propelling our glioblastoma research forward,鈥� said Mills. 鈥淭he investment and exceptional Northwell partnership underscores what鈥檚 possible in the pursuit of cutting-edge genetic discoveries and translating them into novel therapeutic avenues for patients battling such aggressive cancers.鈥�
Funding from groups like the Head for the Cure Foundation is instrumental in empowering the next generation of scientific leaders to advance this crucial work.
鈥淚t is an immense privilege to join Drs. Boockvar and Mills and contribute to the vital research aimed at combating glioblastoma,鈥� said Ertel. 鈥淭his opportunity represents the very essence of translational science鈥攂ridging the gap between fundamental discoveries and life-changing treatments for patients.鈥�
Read the full statement from .
Written by: Communications Department | [email protected] | 516-367-8455